Purpose of review Artificial intelligence is increasingly advancing both fundamental research and clinical applications in schizophrenia. This review surveys recent literature on artificial intelligence driven approaches for schizophrenia diagnosis, treatment, management, and characterization, using multiple data modalities such as neuroimaging, electrophysiology, electronic health records, and genomic data. Recent findings Recent work shows substantial progress in leveraging machine learning and deep learning for diagnostic label prediction, treatment response modeling, and brain network characterization. While many studies continue to improve feature extraction and classification methods within single modalities, there is a growing trend to utilize multiple data sources to capture the complexity of schizophrenia from a comprehensive perspective. Emerging themes include multimodal fusion methodologies to identify linked correlates of schizophrenia, as well as data-driven approaches to learn subgroups, brain networks, and psychosis continua. The rise of large-scale multimodal datasets, foundation models, and mechanistic interpretability methods holds promise for scalable symptom assessment and biomarker identification, thereby better supporting early intervention and personalized treatment. Summary Current literature highlights a shift from unimodal prediction to holistic, multimodal characterization of schizophrenia. Transforming these artificial intelligence models into clinical tools, however, requires careful attention to patient privacy and data bias, alongside rigorous validation across diverse populations and settings.
Li et al. (Tue,) studied this question.